Recent advances in the treatment of FGFR-altered cholangiocarcinoma.

INTRODUCTION: Cholangiocarcinoma (CCA) is a rare, highly lethal biliary malignancy comprising intrahepatic (iCCA), perihilar (pCCA), and distal (dCCA) subtypes, with a rising global incidence. Surgery is the only curative option, yet most patients pr…

Preview only. Read the full abstract at the source